New drugs, or new trials of current drugs, for the treatment of acute ischaemic stroke?
Hankey
G J
GJ
Department of Neurology, Royal Perth Hospital, WA 6001, Perth, Australia. gjhankey@cyllene.uva.edu.au
D001241:Aspirin / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D000078222:Tinzaparin
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D000078222:Tinzaparin; D001241:Aspirin